Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.399 USD | 0.00% | -6.88% | -94.04% |
Apr. 16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- GRI Stock
- News GRI BIOPAR
- Official Publications